| Clinical Biochemistry | Lifetime | 14 | NL 1 | 99.64 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 597 | NL 12 | 98.10 |
| Nephrology | Lifetime | 734 | NL 21 | 89.37 |
| Clinical Biochemistry | 2021-2025 | 2 | NL 1 | 99.01 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 342 | NL 6 | 91.63 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 822 | NL 35 | 83.62 |
| Advanced Glycation End Products research | Lifetime | 18 | NL 1 | 99.60 |
| Natural Antidiabetic Agents Studies | Lifetime | 24 | NL 1 | 99.58 |
| Cardiovascular Health and Disease Prevention | Lifetime | 165 | NL 6 | 99.06 |
| Alcohol Consumption and Health Effects | Lifetime | 146 | NL 2 | 98.51 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 235 | NL 3 | 98.83 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 240 | NL 9 | 99.10 |
| Biochemical effects in animals | Lifetime | 282 | NL 4 | 97.85 |
| Cardiovascular Disease and Adiposity | Lifetime | 373 | NL 13 | 98.07 |
| Diet, Metabolism, and Disease | Lifetime | 448 | NL 9 | 97.80 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 259 | NL 8 | 97.44 |
| Chronic Kidney Disease and Diabetes | Lifetime | 644 | NL 17 | 96.60 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 838 | NL 41 | 95.25 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 894 | NL 18 | 94.64 |
| Biomarkers in Disease Mechanisms | Lifetime | 450 | NL 10 | 87.71 |
| Mangiferin and Mango Extracts | Lifetime | 216 | NL 1 | 67.27 |
| Advanced Glycation End Products research | 2021-2025 | 4 | NL 1 | 98.24 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 191 | NL 10 | 93.40 |
| Natural Antidiabetic Agents Studies | 2021-2025 | 202 | NL 1 | 92.36 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 346 | NL 9 | 92.60 |
| Fatty Acid Research and Health | 2021-2025 | 179 | NL 1 | 89.23 |
| Diet, Metabolism, and Disease | 2021-2025 | 526 | NL 8 | 87.85 |
| Alcohol Consumption and Health Effects | 2021-2025 | 377 | NL 3 | 87.31 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 653 | NL 23 | 77.77 |